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A B S T R A C T  
Objective: 1. To determine the frequency of various factors (patient related, disease related and physician related), 
causing immediate precipitation of congestive cardiac failure in a tertiary care hospital. 2. To establish correlation 
between these variables and severity of decompensated heart failure. 
Patients and Methods: This cross-sectional study was carried out over a period of March-August, 2016. All patients 
admitted to cardiology ward and Coronary Care Unit (CCU) of Pakistan Institute of Medical Sciences during the study 
period were enrolled in the study using consecutive sampling technique. An arbitrarily predetermined sample size of 115 
patients was taken. Precipitants were classified as patient related, disease related and physician related. Data was 
recorded and analyzed using SPSS version 22. Qualitative variables were reported as percentages and quantitative 
variables by using mean ± standard deviation. Spearman correlation coefficient was used to determine the correlation 
between variables and outcome measures. 
Results: A total of 115 patients were enrolled in this study. The mean age of the population was 51.13±13.6 years. 
Among these 38.3% of the population was obese. The patients remained admitted to the hospital for the index episode 
of decompensation for a mean period of 4.14±1.2 days. Infections were found to be the leading precipitant contributing 
to 57.6% of all decompensation episodes. This was followed by drug non-compliance (17.4%) and arrhythmias (8.7%). 
Ischemia was noted in 5.2%. Heart failure severity at presentation was found to correlate significantly with the presence 
of hypertension (Spearman coefficient 0.62, p-value 0.04), baseline hemoglobin (Spearman coefficient -0.58, p-value 
0.03), creatinine levels (Spearman coefficient 0.71, p-value 0.05) and precipitant of heart failure (Spearman coefficient 
0.257, p-value 0.007). 
Conclusion: A sizeable majority of heart failure hospitalizations can be prevented by inculcating measures directed at 
effective infection control at community and health care level and educating patients regarding recognition of early signs 
of infection that may target the most important immediate precipitant for acute decompensated heart failure. 
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I n t r o d u c t i o n  
 
Coinciding with diminutive rates of death from coronary 
artery disease, a parallel rise in mortality from heart failure 
is being observed, which now has taken over as the 
leading cause of cardiovascular mortality.1 Despite the 
advances in therapeutic options for congestive cardiac 
failure, decompensations requiring hospitalization or 
those leading to death are not uncommon.2 The 
prevalence rates are also known to increase in an 
exponential fashion with increasing age; and up-to 10% of 
the people aged 65 years or more are affected by this 
illness.3 It is now the most common cause of 
hospitalization in people of more than 65 years of age.4 
The diagnosis significantly alters the quality of life and 
overall survival, with mortality rates being as high as the 
average mortality rates for the patients with malignancies. 
One -year survival of patients with NYHA (New York 
Heart Association) IV heart failure has been documented 
to be a mere 50%.5 The socioeconomic impact of this 
illness is immense and a major share of that is contributed 
by the in-hospital stay of the patients with heart failure. 
The US health care facilities encounter over 1 million 
hospitalizations each year with a primary diagnosis of 
heart failure 2 and it costs an approximate $34 billion to 
the country’s economy each year.6 A similar trend has 
been noted in the developing world like Pakistan where 
health care facilities continue to be scarce and under 
equipped, and even when present, a lack of access to 
health care for majority of the population makes diseases 
requiring constant medical attention a growing problem. 
No studies reporting the overall incidence and prevalence 
of heart failure are present and the burden of this illness is 
grossly underestimated owing to under reporting and an 
enormous undiagnosed pool of the heart failure iceberg. 
One single center study carried out in 2008-2010 reported 
heart failure as a cause of 22.87% of all hospitalizations 
with an average hospital stay of 4.97 days. 7 In addition, 
hospitalization for heart failure is a documented predictor 
for readmission and death in the post discharge period 
(20% mortality rate after hospitalization).8 Readmission 
rates may range from 27-47% for up-to 6 months 
following the index discharge.9,10 
Many clinical and lifestyle factors are postulated to 
precipitate decompensation of heart failure. These include 
drug non-compliance, myocardial ischemia, arrhythmias, 
infection, anemia, alcohol, pregnancy, worsening 
hypertension, acute valvular insufficiency and use of 
drugs like calcium antagonists, beta-blockers, NSAIDs, 
thiazolidinedione, and class I anti-arrhythmic drugs. The 
impact of these variables on the course of illness may 
both be transient or permanent. Studies conducted in the 
affluent world have identified behavioral factors as the 
primary culprit in altering the clinical course of heart 
failure adversely; of which non-compliance to sodium 
restriction is the major contributor.11  Another study found 
inadequate medical treatment in the outpatient 
department as the major factor leading to 
decompensation.12 However, suboptimal infection control 
practices, over prescription of antibiotics and a low level 
of health education has led to the observation that 
infections may be the primary and the most common 
precipitating factors culminating into decompensated 
heart failure and at times; death, in Pakistan. All of these 
factors are largely modifiable and a correct identification 
may prompt the primary care physicians and cardiologists 
to address these issues systematically, with increased 
vigilance leading to an improved clinical course and 
reduced economic impact of heart failure on Pakistan’s 
already failing economy. 
P a t i e n t s  a n d  M e t h o d s  
This cross-sectional study was carried out from March-
August, 2016. Sample size was determined through WHO 
sample size calculator using 95% Confidence interval, 
80% power of test and anticipated population proportion 
8.1%.3 Calculated sample size was 115 patients. Patients 
admitted to cardiology ward and Coronary Care Unit 
(CCU) of Pakistan Institute of Medical Sciences were 
enrolled in the study using consecutive sampling. Acute 
decompensated heart failure was defined as any sudden 
or gradual onset of symptoms suggestive of heart failure 
warranting unscheduled OPD visits, emergency room 
visits or hospital admissions. Patients were considered 
eligible to enter into the study if they had a previous or 
current diagnosis of heart failure due to any cause and if 
the primary admitting diagnosis was acute 
decompensated heart failure. Patients with severe  
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psychiatric illnesses, severe dementia, malignancies or 
patients with an anticipated survival of less than a week 
were excluded from the study. All patients provided 
written informed consent. The hospital’s ethical review 
board approved the study. Presenting symptoms and 
examination findings were noted and NYHA classification 
for dyspnea at the time of presentation was used to 
gauge the severity of the index hospital visit. Pertinent lab 
data were acquired which included ECG, 
echocardiogram, blood complete picture, renal and liver 
functions tests, electrolytes, chest X ray and pregnancy 
test (if applicable). Trained hospital physicians conducted 
the interview during admission using an objectively 
structured questionnaire.  
Figure 1: Distribution of study population according 
to clinical diagnosis (n=115) 
Data was recorded and analyzed using SPSS version 
22.0. Qualitative variables were reported as percentages 
and quantitative variables by using mean ± standard 
deviation. Spearman correlation coefficient was used to 
determine the correlation between variables and outcome 
measures. A p-value of <0.05 was considered to be 
statistically significant.  
R e s u l t s  
A total of 115 patients were included in this study after 
screening for inclusion and exclusion criteria and 
obtaining written informed consent. The baseline 
characteristics of this population are described in table 1. 
The mean age of the population was 51.13±13.6 years. 
Percentage of obesity was 38.3. Mean hemoglobin was 
found to be 13.47±2.12 g/dL and the mean creatinine was 
1.92±0.99 mg/dL. The patients remained admitted to the 
hospital for the index episode of decompensation for a 
mean period of 4.14±1.2 days (maximum 8 days).  
Out of 115, maximum number of patients (n=53) were 
diagnosed to have idiopathic dilated cardiomyopathy. The 
distribution of patients according to their clinical diagnosis 
is as shown in Figure 1. In total 34.8% of the patients had 
a NYHA III dyspnea at the time of admission and 65.2% 
had NYHA IV dyspnea at presentation. The patients had 
an average of 2.14±1.4 admissions over the preceding 6 
months for this illness (maximum 6). The trends of 
precipitants of heart failure that were observed on 
analysis are shown in table 2.  
Table 2: Trends in distribution of immediate 
precipitants of heart failure decompensation in 
study participants (n=115) 
Immediate precipitant Number (%) 
Respiratory tract infection 46(40) 
Urinary Tract infections 11(9.6) 
Other infections (e.g. cellulitis) 8(07) 
Anaemia 8(07) 
Myocardial Ischemia 6(5.2) 
Uncontrolled hypertension 6(5.2) 
Arrhythmia 10(8.7) 
Drug non compliance 20(17.4) 
Table 1: Baseline characteristics of the study 
population (n=115) 
Parameter Status Frequency Percentage 
Hypertension Non 
Hypertensive 
45 39.1 
Hypertensive 70 60.9 
Diabetes Non Diabetic 63 54.8 
Diabetic 52 45.2 
Smoking No 73 63.5 
Yes 42 36.5 
Dyslipidaemia No 84 73 
Yes 31 27 
Lifestyle Sedentary 53 46.1 
Active 62 53.9 
Socioeconomic 
status 
Upper 8 7 
Middle 34 29.6 
Lower 73 63.5 
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Heart failure severity at presentation was found to 
correlate significantly with the presence of hypertension, 
baseline hemoglobin levels, baseline creatinine levels and 
precipitant of heart failure (Table 3). The number of 
hospitalizations over preceding 6 months correlated 
significantly with lifestyle and heart failure precipitant. The 
length of index hospital stay was also found to correlate 
significantly with age (Table 3). 
Table 3: Correlation of heart failure 
severity/hospitalization with different variables of 
study (n=115) 
Parameters Variables Correlation 
Coefficient 
p-value 
Heart failure 
severity at 
presentation 
Hypertension 0.62 0.04 
Hemoglobin 
levels 
-0.58 0.03 
Creatinine 
levels 
0.71 0.05 
Nature of heart 
failure 
precipitant 
0.257 0.007 
Number of 
hospitalizations 
for heart failure 
over past 6 
months 
Lifestyle 0.186 0.047 
Nature of heart 
failure 
precipitant 
0.199 0.033 
Length of index 
hospitalization 
Age 0.210 0.022 
D i s c u s s i o n  
Heart failure represents a growing health related problem 
globally with more than 20 million people affected world 
over.6 An exponential rise in incidence with age has also 
been reported and this impact is further amplified on 
account of heart failure being the most common reason 
for hospitalization in the elderly.4  All hospitalizations for 
decompensated heart failure are associated with 
substantial increase in mortality, morbidity and risk of re-
hospitalization as compared to clinically stable heart 
failure.13,14 In this light, targeting modifiable precipitants of 
decompensation may lead to significant improvement in 
overall mortality, morbidity and quality of life of heart 
failure patients. The present study was instituted with this 
aim that may prove to be a stepping stone for enhanced 
health care delivery for patients affected with heart failure. 
The mean patient age in the present cohort was 51.13 
years in contrast to a higher mean age of 73.1 years in a 
similar istudy.15 This difference may have arisen due to a 
higher prevalence of post myocarditis dilated 
cardiomyopathy in our population which tends to affect 
younger age groups. Majority of patients presented with 
NYHA IV symptom severity in our study consistent with 
similar findings noted in another study carried out on a 
resource rich population.16 Ninety-nine percent patients 
had a history of at least one previous hospital admission 
over the last 6 months comparable albeit higher than a 
value of 72.6% in the aforementioned study.16 
The present study identified infection as the major 
immediate precipitant of decompensated heart failure 
accounting for 56.6% of all hospitalizations (respiratory 
infection being the most common one) followed by drug 
noncompliance, arrhythmia and anaemia. Previous 
studies carried out in resource rich populations have 
documented ischemia, drug non-compliance, dietary 
sodium excess, arrhythmias but no such study except 
OPTIMIZE-HF identified infection as the major factor, and 
in that too, it constituted only 15% of total 
decompensation events in contrast to 55.6% in ours.15-18 
This reflects the role of poor infection control practices in 
our population along with suboptimal antibiotic prescribing 
practices giving rise to more frequent and rampant 
infections. This is also one of the major modifiable factors 
implicated in heart failure hospitalizations. To the best of 
our knowledge, correlation of patient and disease related 
factors with severity of heart failure at presentation, length 
of hospital stay and number of hospitalization has not 
been studied previously. 
C o n c l u s i o n  
A sizeable majority of heart failure hospitalizations can be 
prevented by inculcating measures directed at effective 
infection control at health care level and educating 
patients regarding recognition of early signs of infection 
that may target the most important immediate precipitant 
for acute decompensated heart failure. 
                            223 JIMDC  2017  223 
R e f e r e n c e s  
1. Colombo PC, Doran AC, Onat D, Wong KY, Ahmad M, 
Sabbah HN, Demmer RT. Venous congestion, endothelial 
and neurohormonal activation in acute decompensated 
heart failure: cause or effect? Current heart failure reports. 
2015; 12(3):215-22.  
2. Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock 
WF, Laribi S, Ristic AD, Lambrinou E, Masip J, Riley JP, 
McDonagh T. Recommendations on pre‐hospital & early 
hospital management of acute heart failure: a consensus 
paper from the Heart Failure Association of the European 
Society of Cardiology, the European Society of Emergency 
Medicine and the Society of Academic Emergency 
Medicine. European journal of heart failure. 2015; 
17(6):544-58.  
3. Joseph SM, Cedars AM, Ewald GA, Geltman EM, Mann 
DL. Acute decompensated heart failure. Tex Heart Inst 
J 2009; 36(6): 510-520. 
4. Yeh JK, Hsiao YC, Jian CR, Wang CH, Wen MS, Kuo CT, 
Tsai FC, Wu VC, Chen TH. Comparison of baseline versus 
posttreatment left ventricular ejection fraction in patients 
with acute decompensated heart failure for predicting 
cardiovascular outcome: implications from single-center 
systolic heart failure cohort. PloS one. 2016; 11(1): 
e0145514.  
5. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, 
Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi 
JL, Johnson MR. 2013 ACCF/AHA guideline for the 
management of heart failure. Circulation. 2013: CIR-
0b013e31829e8776.  
6. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene 
SJ, Vaduganathan M, Nodari S, Lam CS, Sato N, Shah 
AN, Gheorghiade M. The global health and economic 
burden of hospitalizations for heart failure: lessons learned 
from hospitalized heart failure registries. Journal of the 
American College of Cardiology. 2014;63(12):1123-33.  
7. Noor L, Adnan Y, Khan SB, Shah SS, Sarwar S, Qadoos A 
et al. In patient burden of heart failure in the Cardiology 
units of tertiary care hospitals in Peshawar. Pak J 
Physiol 2012; 8(1): 3-6. 
8. Givertz MM, Teerlink JR, Albert NM, Canary CA, Collins 
SP, Colvin-Adams M, Ezekowitz JA, Fang JC, Hernandez 
AF, Katz SD, Krishnamani R. Acute decompensated heart 
failure: update on new and emerging evidence and 
directions for future research. Journal of cardiac failure. 
2013; 19(6):371-89.  
9. Patel MD, Kalbaugh CA, Chang PP, Matsushita K, 
Agarwal SK, Caughey MC, Ni H, Rosamond WD, Wruck 
LM, Loehr LR. Characteristics and outcomes of patients 
with acute decompensated heart failure developing after 
hospital admission. The American journal of cardiology. 
2014; 114(10):1530-6. 
10. Whellan DJ, Stebbins A, Hernandez AF, Ezekowitz JA, 
McMurray JJ, Mather PJ, Hasselblad V, O'Connor CM. 
Dichotomous relationship between age and 30-day death 
or rehospitalization in heart failure patients admitted with 
acute decompensated heart failure: results from the 
ASCEND-HF trial. Journal of cardiac failure. 2016; 
22(6):409-16. 
11. Lassus J, Gayat E, Mueller C, Peacock WF, Spinar J, 
Harjola VP, van Kimmenade R, Pathak A, Mueller T, Metra 
M, Pascual-Figal D. Incremental value of biomarkers to 
clinical variables for mortality prediction in acutely 
decompensated heart failure: The Multinational 
Observational Cohort on Acute Heart Failure (MOCA) 
study. International journal of cardiology. 2013; 
168(3):2186-94.  
12. Wu MY, Chang NC, Su CL, Hsu YH, Chen TW, Lin YF, Wu 
CH, Tam KW. Loop diuretic strategies in patients with 
acute decompensated heart failure: a meta-analysis of 
randomized controlled trials. Journal of critical care. 2014; 
29(1):2-9. 
13. Heart Failure Society of America. HFSA 2010 
comprehensive heart failure practice guideline. J Card Fail. 
2010;16: e1-94. 
14. Platz E, Jhund PS, Campbell RT, McMurray JJ. 
Assessment and prevalence of pulmonary oedema in 
contemporary acute heart failure trials: a systematic 
review. European journal of heart failure. 2015; 17(9):906-
16. 
15. Fonarow GC, Abraham WT, Albert NM, Stough WG, 
Gheorghiade M, Greenberg BH, O’Connor CM, Pieper K, 
Sun JL, Yancy CW, Young JB. Factors identified as 
precipitating hospital admissions for heart failure and 
clinical outcomes: findings from OPTIMIZE-HF.  
Archives of internal medicine. 2008; 168(8):847- 
54. 
16. Farmakis D, Parissis J, Lekakis J, Filippatos G. Acute 
heart failure: epidemiology, risk factors, and prevention. 
Revista Española de Cardiología (English Edition). 2015; 
68(3):245-8. 
17. Arrigo M, Parissis JT, Akiyama E, Mebazaa A. 
Understanding acute heart failure: pathophysiology and 
diagnosis. European Heart Journal Supplements. 2016; 
18(suppl G): G11-8. 
18. Tsuyuki RT, McKelvie RS, Arnold JM, Avezum Jr A, 
Barretto AC, Carvalho AC, Isaac DL, Kitching AD, Piegas 
LS, Teo KK, Yusuf S. Acute precipitants of congestive 
heart failure exacerbations. Archives of Internal Medicine. 
2001; 161(19):2337-42. 
 
